Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease.
about
Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophagesRespiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells.LITAF mediation of increased TNF-α secretion from inflamed colonic lamina propria macrophages.Early mucosal changes in Crohn's disease.Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes.Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.Lymphocyte and macrophage subpopulations in pelvic ileal pouches.Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.Whipple's disease: a macrophage diseaseIntestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis.High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells.Elastic scattering spectroscopy as an optical marker of inflammatory bowel disease activity and subtypes.Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.Histologic scoring indices for evaluation of disease activity in Crohn's disease.Anti-inflammatory Effect of Amitriptyline on Ulcerative Colitis in Normal and Reserpine-Induced Depressed Rats.Adherence of RFD-1 positive dendritic cells to the basal surface of thyroid follicular cells in Graves' disease.Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.Interleukin-2 receptor expression.Immunity in the female lower genital tract and the impact of HIV infection.Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases.Differentiation between ulcerative colitis and Crohn's disease by a quantitative immunohistochemical evaluation of T lymphocytes, neutrophils, histiocytes and mast cells.
P2860
Q28344913-1E425919-3105-4836-A893-C6E58D266E6CQ28367804-DCC7AB60-F8AA-41D4-92D8-85542B5D2E6AQ34045034-D6CC25BF-A6C0-491B-8077-5B64677267A0Q34376449-542170C6-E8E0-4D3C-8FE7-7DC253606F6DQ34377789-F288CA47-5261-4400-A4F2-4F1553B818F0Q34378707-804C0645-39CF-452B-86B5-05CB4CF2CA08Q34393256-F93C7FE2-58D2-42D5-8283-C16D674FD986Q34395629-6DB7BD28-5B1F-411E-B008-558817F3988CQ34396124-BE06B053-0104-470A-B1D5-786CE5F45697Q34429342-629D8137-6525-4182-AEC4-BCCE0BBDFFC3Q35062094-0492A4F3-2E5E-40E5-BDF3-743CDF998B80Q35351584-3435EF9F-2FBF-4481-BF4C-6CE98C309D29Q35773643-D59A3B13-8E77-4D50-A07B-58507F8D3C13Q36874416-46F234CF-8B1B-41B4-8A8A-D27244687C88Q37638947-19A25B0C-40AD-4A88-A2CA-CC673FF246A1Q38668188-51C67401-023E-415F-9877-D8A0543F8597Q42087210-3F86A404-2612-47C6-ABF8-7F679D2CE6D1Q42495175-5FDD053E-D27C-4492-BAC8-A76D7683AA69Q43202907-52CB58A4-FF22-4ED6-A78D-B67713EDF88DQ43220729-CF0915B8-18F0-4EB4-B696-0D9D1D183B00Q44212305-A40D223C-7D69-4896-929A-950DAAFEB91AQ47102876-3216DFDD-E30E-4104-A636-F813766B2EEBQ52039852-37DCC403-1943-4A24-A37C-C70B5CD370C0
P2860
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease.
@en
type
label
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease.
@en
prefLabel
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease.
@en
P2093
P2860
P356
P1433
P1476
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease.
@en
P2093
A P Dhillon
L W Poulter
M C Allison
R E Pounder
S Cornwall
P2860
P304
P356
10.1136/GUT.29.11.1531
P407
P577
1988-11-01T00:00:00Z